Crossmark

BLyS/APRIL dual inhibition by telitacicept for refractory pemphigus vulgaris combined with hepatocellular cancer

Crossref DOI link: https://doi.org/10.1016/j.abd.2025.501263

Published Print: 2026-01

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Chen, Weiyu

Xu, Jian

Zhang, Yamin https://orcid.org/0000-0002-4170-5897
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (82003366)

National Natural Science Foundation of China (82000223)
License Information

Text and Data Mining valid from 2026-01-01

Text and Data Mining valid from 2026-01-01

Version of Record valid from 2025-12-13
More Information

This article is maintained by: Elsevier

Article Title: BLyS/APRIL dual inhibition by telitacicept for refractory pemphigus vulgaris combined with hepatocellular cancer

Journal Title: Anais Brasileiros de Dermatologia

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.abd.2025.501263

Content Type: article

Copyright: © 2025 Sociedade Brasileira de Dermatologia. Published by Elsevier España, S.L.U.